Riskpilot← Back to searchSign inGet full accessNOVELAKLINIKKEN DRAMMEN AS
ASActiveOrg 985036284Guldlisten 35, 3048 DrammenBeauty care and other beauty treatment activities · NACE 9622Est. 20026 employees
Revenue 2024
NOK 3M
-27% vs 2023
EBITDA margin
-4.4%
+57% vs 2023
Equity ratio
4.4%
Financial strength
Net profit 2024
NOK -165K
+49% vs 2023
| Revenue | NOK 3M | -27% |
| EBITDA | NOK -132K | +57% |
| Net profit | NOK -165K | +49% |
| Total assets | NOK 1M | -23% |
| Equity | NOK 46K | +93% |
| Employees | 6 | — |
Legal name
NOVELAKLINIKKEN DRAMMEN AS
Org number
985036284
Legal form
Aksjeselskap
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
13. november 2002
Share capital
NOK 100 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Estetisk hud og hårbehandlinger, samt det som naturlig hører inn under dette. Selskapet kan også ved aksjetegning eller på annen måte å delta i andre foretak.
Address
Guldlisten 35, 3048 Drammen
Phone
+4732828682
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 131 | 4 181 | 4 061 | 4 087 | 2 986 |
| Staff expenses | −1 843 | −1 773 | −1 866 | −2 036 | −1 715 |
| EBITDA | −18 | 30 | −64 | −307 | −132 |
| Depreciation & amort. | −113 | −60 | −30 | −20 | −33 |
| EBIT | −131 | −30 | −94 | −327 | −165 |
| Net financials | −2 | −0 | 0 | 1 | −0 |
| Profit before tax | −133 | −31 | −94 | −326 | −165 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −133 | −31 | −94 | −326 | −165 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 602 | 807 | 1 040 | 1 364 | 1 044 |
| Equity | −124 | −64 | −16 | 24 | 46 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 726 | 871 | 1 056 | 1 340 | 998 |
| Total debt | 726 | 871 | 1 056 | 1 340 | 998 |
EBITDA margin
-4.4%
This company
15.8%
Market median
-128% vs market
20202024
Equity ratio
4.4%
This company
38.2%
Market median
-88% vs market
20202024
Return on equity
-357.4%
This company
18.4%
Market median
-2042% vs market
20202024
Net profit margin
-5.5%
This company
8.1%
Market median
-168% vs market
20202024
Asset turnover
2.86×
This company
1.12×
Market median
+155% vs market
20202024
Debt / equity
21.62×
This company
0.62×
Market median
-3387% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LB Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (2) | ||
GA Deputy Member | Deputy Member | 2019 – 2022 |
IV Chief Executive Officer | Chief Executive Officer | 2007 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Midgard Eiendom As
NOVELAKLINIKKEN DRAMMEN AS Board members of NOVELAKLINIKKEN DRAMMEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leila Bäcklund | Chief Executive Officer | 0 companies |
| Geir Anders Viken | Deputy Member | 0 companies |
| Ingrid Viken | Chief Executive Officer | 0 companies |
| Nikolai Paus Grova | Chairman | 0 companies |